Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Palisade Bio, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q2 2021
- Shares held
- 766.3K
- −1.72M (−69.2%) vs. Q2 2021
- Total value
- $2.03M
- −$8.09M (−80.0%) vs. Q2 2021
- New holders
- 2
- 9 more added
- Sold out
- 3
- 2 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PALI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $362.4M |
| Q1 2026 | 96 | $261.7M |
| Q4 2025 | 86 | $319.4M |
| Q3 2025 | 12 | $102.8K |
| Q2 2025 | 11 | $57.5K |
| Q1 2025 | 13 | $200.9K |
| Q4 2024 | 10 | $387.7K |
| Q3 2024 | 9 | $347.4K |
| Q2 2024 | 8 | $297.7K |
| Q1 2024 | 16 | $384.6K |
| Q4 2023 | 16 | $158.3K |
| Q3 2023 | 13 | $86.6K |
| Q2 2023 | 11 | $228.7K |
| Q1 2023 | 9 | $29.8K |
| Q4 2022 | 12 | $648.0K |
| Q3 2022 | 33 | $842.0K |
| Q2 2022 | 26 | $395.0K |
| Q1 2022 | 25 | $930.0K |
| Q4 2021 | 28 | $1.70M |
| Q3 2021 | 22 | $2.03M |
| Q2 2021 | 23 | $10.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Palisade Bio, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 243,590 | $645.0K | 0.00% | +5,779+2.4% | Added |
| Geode Capital Management, LLC | 171,530 | $454.0K | 0.00% | +146,855+595.2% | Added |
| Sargent Investment Group, LLC | 105,000 | $278.0K | 0.07% | +105,000 | New |
| Strategic Wealth Designers | 53,129 | $141.0K | 0.04% | 00.0% | Unchanged |
| Sabby Management, LLC | 52,500 | $139.0K | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 28,841 | $76.0K | 0.00% | +4,134+16.7% | Added |
| State Street Corp | 28,210 | $75.0K | 0.00% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 23,551 | $62.0K | 0.00% | +2,500+11.9% | Added |
| Virtu Financial LLC | 17,612 | $47.0K | 0.00% | −588−3.2% | Reduced |
| HighTower Advisors, LLC | 16,666 | $44.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,519 | $28.0K | 0.00% | +94+0.9% | Added |
| Wells Fargo & Company | 6,290 | $16.0K | 0.00% | +6,050+2,520.8% | Added |
| Morgan Stanley | 4,675 | $12.0K | 0.00% | +740+18.8% | Added |
| UBS Group AG | 2,264 | $6.00K | 0.00% | −19,874−89.8% | Reduced |
| Evermay Wealth Management LLC | 1,719 | $5.00K | 0.00% | +53+3.2% | Added |
| Bank of America Corp | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 87 | $0 | 0.00% | +1+1.2% | Added |
| Sterling Investment Advisors, Ltd. | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Centerpoint Advisors, LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 34 | $0 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 62 | $0 | 0.00% | +62 | New |
| Altium Capital Management LP | 0 | $0 | 0.00% | −1,824,894−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −145,300−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −909−100.0% | Sold out |